The Shifting Omega-3 Paradigm: From Intake to Uptake

Dr. Clemens von Schacky

Clemens von Schacky, an Internist and Cardiologist, is leading the unit of Preventive Cardiology at the Ludwig Maximilians-University of Munich. Dr. von Schacky's research focuses on cardiovascular prevention, such as omega-3 fatty acids, aspirin, ACE-inhibitors, diabetes, with over 120 peer-reviewed publications. Together with William Harris, he invented and defined the Omega-3 Index, a standardized method for erythrocyte fatty acid analysis, now brand-marked "HS-Omega-3 Index®", substantiated by 220 publications in international journals, and more than 50 ongoing research projects. Dr. von Schacky founded Omegametrix in Martinsried, Germany, which measures the HS-Omega-3 Index. His work has been recognized with numerous honors, including the Global Organization for EPA and DHA (GOED) 2016 award for global leadership in omega-3's.

Dr. Joseph Moritz

Joseph Moritz, PhD. is Scientific Manager for BASF Human Nutrition, North America. His responsibilities include innovation, clinical trial coordination, scientific communications, and customer claims substantiation. Dr. Moritz leads BASF's Omega-3 bioavailability programs in North America. His science expertise combined with his business experience helps him support customers in translating the science so it resonates with consumers. He earned his Ph.D. in Chemical Engineering from Massachusetts Institute of Technology.

Adam Ismail

Adam Ismail is Executive Director of the Global Organization for EPA and DHA Omega-3s (GOED), where he has overseen growth since its founding in 2007 to 200 members worldwide, working to promote sufficient consumption of omega-3s, protecting the category, and ensuring consumers have access to high quality omega-3 products they can trust. Previously, he worked for Cargill, commercializing their omega-3 food ingredient business, and at HSC and Health Business Partners in investment banking and strategy consulting.